Louise Otto

1.1k total citations
18 papers, 663 citations indexed

About

Louise Otto is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Louise Otto has authored 18 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 9 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Louise Otto's work include Neurogenetic and Muscular Disorders Research (14 papers), Congenital Anomalies and Fetal Surgery (8 papers) and RNA modifications and cancer (7 papers). Louise Otto is often cited by papers focused on Neurogenetic and Muscular Disorders Research (14 papers), Congenital Anomalies and Fetal Surgery (8 papers) and RNA modifications and cancer (7 papers). Louise Otto collaborates with scholars based in Netherlands, Germany and United States. Louise Otto's co-authors include W. Ludo van der Pol, Renske I. Wadman, Camiel A. Wijngaarde, Inge Cuppen, Marloes Stam, Bart Bartels, Ruben P. A. van Eijk, Fay‐Lynn Asselman, Leonard H. van den Berg and Marja Schoenmakers and has published in prestigious journals such as Neurology, The Journal of Comparative Neurology and Magnetic Resonance in Medicine.

In The Last Decade

Louise Otto

17 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise Otto Netherlands 13 511 352 285 101 69 18 663
Inge Cuppen Netherlands 18 661 1.3× 472 1.3× 404 1.4× 99 1.0× 31 0.4× 41 934
D. Vlodavets Russia 9 267 0.5× 166 0.5× 265 0.9× 49 0.5× 50 0.7× 52 454
Bakri Elsheikh United States 16 484 0.9× 296 0.8× 343 1.2× 70 0.7× 41 0.6× 42 726
Marloes Stam Netherlands 18 742 1.5× 461 1.3× 406 1.4× 118 1.2× 17 0.2× 25 851
Marco Pelliccioni Italy 7 440 0.9× 250 0.7× 427 1.5× 78 0.8× 13 0.2× 8 665
Janine Wood United States 6 345 0.7× 198 0.6× 225 0.8× 37 0.4× 19 0.3× 8 425
Andreas Totzeck Germany 13 249 0.5× 158 0.4× 391 1.4× 30 0.3× 8 0.1× 28 677
Ziga Cizman United States 7 188 0.4× 95 0.3× 287 1.0× 23 0.2× 64 0.9× 19 492
Riccardo Masson Italy 12 622 1.2× 337 1.0× 458 1.6× 65 0.6× 2 0.0× 46 761
Astrid Pechmann Germany 13 476 0.9× 298 0.8× 301 1.1× 87 0.9× 2 0.0× 34 630

Countries citing papers authored by Louise Otto

Since Specialization
Citations

This map shows the geographic impact of Louise Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Otto more than expected).

Fields of papers citing papers by Louise Otto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Otto. The network helps show where Louise Otto may publish in the future.

Co-authorship network of co-authors of Louise Otto

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Otto. A scholar is included among the top collaborators of Louise Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Otto. Louise Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Veldhoen, Esther S., Camiel A. Wijngaarde, Ruben P. A. van Eijk, et al.. (2023). Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study. Orphanet Journal of Rare Diseases. 18(1). 40–40. 5 indexed citations
2.
Otto, Louise, Martijn Froeling, Ruben P. A. van Eijk, et al.. (2023). Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI. Journal of Neuromuscular Diseases. 11(1). 91–101. 7 indexed citations
3.
Veldhoen, Esther S., Camiel A. Wijngaarde, Erik H.J. Hulzebos, et al.. (2022). Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study. Orphanet Journal of Rare Diseases. 17(1). 70–70. 19 indexed citations
4.
Stam, Marloes, Camiel A. Wijngaarde, Bart Bartels, et al.. (2022). Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4. Brain Communications. 5(1). fcac324–fcac324. 18 indexed citations
5.
Otto, Louise, Martijn Froeling, Ruben P. A. van Eijk, et al.. (2021). Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study. NMR in Biomedicine. 34(4). e4473–e4473. 28 indexed citations
6.
Otto, Louise, Roel Haeren, Govert Hoogland, et al.. (2020). Shedding light on human cerebral lipofuscin: An explorative study on identification and quantification. The Journal of Comparative Neurology. 529(3). 605–615. 8 indexed citations
7.
Sleutjes, Boudewijn T.H.M., Camiel A. Wijngaarde, Renske I. Wadman, et al.. (2020). Assessment of motor unit loss in patients with spinal muscular atrophy. Clinical Neurophysiology. 131(6). 1280–1286. 25 indexed citations
8.
Wijngaarde, Camiel A., Esther S. Veldhoen, Ruben P. A. van Eijk, et al.. (2020). Natural history of lung function in spinal muscular atrophy. Orphanet Journal of Rare Diseases. 15(1). 88–88. 63 indexed citations
9.
Otto, Louise, W. Ludo van der Pol, Lara Schlaffke, et al.. (2020). Quantitative MRI of skeletal muscle in a cross‐sectional cohort of patients with spinal muscular atrophy types 2 and 3. NMR in Biomedicine. 33(10). e4357–e4357. 41 indexed citations
10.
Wijngaarde, Camiel A., Marloes Stam, Louise Otto, et al.. (2020). Population-based analysis of survival in spinal muscular atrophy. Neurology. 94(15). e1634–e1644. 58 indexed citations
11.
Keene, Kevin R., Jan‐Willem M. Beenakker, Melissa T. Hooijmans, et al.. (2020). T2 relaxation‐time mapping in healthy and diseased skeletal muscle using extended phase graph algorithms. Magnetic Resonance in Medicine. 84(5). 2656–2670. 33 indexed citations
12.
Wijngaarde, Camiel A., Marloes Stam, Louise Otto, et al.. (2020). Muscle strength and motor function in adolescents and adults with spinal muscular atrophy. Neurology. 95(14). e1988–e1998. 51 indexed citations
13.
Stam, Marloes, Martijn Froeling, M.E.P. Philippens, et al.. (2019). Magnetic resonance imaging of the cervical spinal cord in spinal muscular atrophy. NeuroImage Clinical. 24. 102002–102002. 10 indexed citations
14.
Schlaffke, Lara, Robert Rehmann, Louise Otto, et al.. (2019). Multi‐center evaluation of stability and reproducibility of quantitative MRI measures in healthy calf muscles. NMR in Biomedicine. 32(9). e4119–e4119. 71 indexed citations
15.
Wijngaarde, Camiel A., Rob C. Brink, Marloes Stam, et al.. (2019). Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy. Neurology. 93(2). e149–e158. 59 indexed citations
16.
Stam, Marloes, Renske I. Wadman, Camiel A. Wijngaarde, et al.. (2018). Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial). BMJ Open. 8(7). e019932–e019932. 32 indexed citations
17.
Wadman, Renske I., Camiel A. Wijngaarde, Marloes Stam, et al.. (2017). Muscle strength and motor function throughout life in a cross‐sectional cohort of 180 patients with spinal muscular atrophy types 1c–4. European Journal of Neurology. 25(3). 512–518. 135 indexed citations
18.
Otto, Louise. (1980). Sendschreiben an alle »Verbrüderten«. ScholarsArchive (Brigham Young University).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026